Company intelligence / Profile preview

Mega Trading

Ownership: Private
Development stage: Other

Overview

Mega Life Science is dedicated to supplying advanced laboratory diagnostics and life science products—including state-of-the-art equipment and reagents—to healthcare providers, laboratories, research facilities, and educational institutions. The company focuses on bridging innovation with implementation by partnering with leading manufacturers of diagnostic technologies. It does not appear to have its own drug development pipeline or clinical programs but plays a key role as an enabler of scientific progress through distribution of high-quality tools.

Industry: Non-Drug Biotech

Partnerships

Strategic partnerships with leading manufacturers of diagnostic technologies. Specific partners are not named.

Beyond the preview

Go deeper on Mega Trading.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mega Trading.

Explore the full profile